Used in biomedical research to measure glucagon-like peptide 2 (GLP-2) levels in rat samples, this ELISA kit enables the study of gut health and intestinal function. It is commonly applied in preclinical studies related to gastrointestinal diseases, such as inflammatory bowel disease (IBD) and short bowel syndrome. Researchers use it to evaluate the effects of therapeutic compounds on GLP-2 secretion, assess intestinal growth and repair, and understand nutrient absorption mechanisms. The kit supports high-throughput, quantitative analysis of GLP-2 in serum, plasma, or cell culture supernatants, making it a valuable tool in metabolic and endocrine research.